| 401 | LNSRLENSAR, Inc. |
58,4 M US$ |
-58,7% |
2025 |
| 402 | AYTUAytu Biopharma, Inc |
57,6 M US$ |
-24,8% |
2026 |
| 403 | CVRXCVRx, Inc. |
56,7 M US$ |
-94,1% |
2025 |
| 404 | NKTRNektar Therapeutics |
55,2 M US$ |
-297,1% |
2025 |
| 405 | IMCCIM Cannabis Corp. |
54,7 M CAD |
-20,7% |
2025 |
| 406 | AGIOAgios Pharmaceuticals, Inc. |
54 M US$ |
-764,0% |
2025 |
| 407 | QTTBQ32 Bio Inc. |
53,7 M US$ |
55,5% |
2025 |
| 408 | IVVDInvivyd, Inc. |
53,4 M US$ |
-98,2% |
2025 |
| 409 | APYXApyx Medical Corp |
52,8 M US$ |
-21,2% |
2025 |
| 410 | PLXProtalix BioTherapeutics, Inc. |
52,7 M US$ |
-12,5% |
2025 |
| 411 | IRIXIridex Corp |
52,7 M US$ |
-8,4% |
2026 |
| 412 | OCULOcular Therapeutix, Inc |
52 M US$ |
-511,9% |
2025 |
| 413 | CARLCarlsmed, Inc. |
50,5 M US$ |
-58,7% |
2025 |
| 414 | LXRXLexicon Pharmaceuticals, Inc. |
49,8 M US$ |
-101,1% |
2025 |
| 415 | GOSSGossamer Bio, Inc. |
48,5 M US$ |
-351,5% |
2025 |
| 416 | SIShoulder Innovations, Inc. |
47,3 M US$ |
-85,3% |
2025 |
| 417 | CAPSCapstone Holding Corp. |
46,9 M US$ |
-45,3% |
2025 |
| 418 | PTGXProtagonist Therapeutics, Inc |
46 M US$ |
-282,8% |
2025 |
| 419 | SEPNSepterna, Inc. |
46 M US$ |
-106,4% |
2025 |
| 420 | TLSITriSalus Life Sciences, Inc. |
45,2 M US$ |
-86,9% |
2025 |
| 421 | FENCFennec Pharmaceuticals Inc. |
44,6 M US$ |
-21,8% |
2025 |
| 422 | AQSTAquestive Therapeutics, Inc. |
44,5 M US$ |
-188,1% |
2025 |
| 423 | CPIXCumberland Pharmaceuticals Inc |
44,5 M US$ |
-6,4% |
2025 |
| 424 | SNWVSANUWAVE Health, Inc. |
44,1 M US$ |
26,8% |
2025 |
| 425 | INBPIntegrated Biopharma Inc |
43,9 M US$ |
-6,5% |
2026 |
| 426 | XLOXilio Therapeutics, Inc. |
43,8 M US$ |
-80,1% |
2025 |
| 427 | WVEWave Life Sciences Ltd. |
42,7 M US$ |
-478,3% |
2025 |
| 428 | SSIISS Innovations International, Inc. |
42,5 M US$ |
-28,5% |
2025 |
| 429 | CHRSCoherus Oncology, Inc. |
42,2 M US$ |
398,4% |
2025 |
| 430 | BFRIBiofrontera Inc. |
41,7 M US$ |
-25,3% |
2025 |
| 431 | KRMDKORU Medical Systems, Inc. |
41,1 M US$ |
-6,4% |
2025 |
| 432 | BWAYBrainsway Ltd. |
41 M US$ |
7,1% |
2024 |
| 433 | MYOMyomo, Inc. |
40,9 M US$ |
-38,1% |
2025 |
| 434 | EDITEditas Medicine, Inc. |
40,5 M US$ |
-395,0% |
2025 |
| 435 | TKNOAlpha Teknova, Inc. |
40,5 M US$ |
-42,6% |
2025 |
| 436 | VYGRVoyager Therapeutics, Inc. |
40,4 M US$ |
-296,5% |
2025 |
| 437 | SGMOQSangamo Therapeutics, Inc |
39,6 M US$ |
-310,8% |
2025 |
| 438 | KYMRKymera Therapeutics, Inc. |
39,2 M US$ |
-794,0% |
2025 |
| 439 | IDXGInterpace Biosciences, Inc. |
38,7 M US$ |
63,5% |
2025 |
| 440 | UTMDUtah Medical Products Inc |
38,5 M US$ |
29,3% |
2025 |
| 441 | RVPRetractable Technologies Inc |
38,3 M US$ |
-32,8% |
2025 |
| 442 | BGMBGM Group Ltd. |
37,9 M US$ |
-52,6% |
2025 |
| 443 | CTSOCytosorbents Corp |
37,1 M US$ |
-22,1% |
2025 |
| 444 | CLPTClearPoint Neuro, Inc. |
37 M US$ |
-69,1% |
2025 |
| 445 | LIFDLftd Partners Inc. |
36,9 M US$ |
-67,3% |
2025 |
| 446 | SBFMSunshine Biopharma Inc. |
36,3 M US$ |
-16,5% |
2025 |
| 447 | CCCCC4 Therapeutics, Inc. |
35,9 M US$ |
-292,1% |
2025 |
| 448 | ETSTEarth Science Tech, Inc. |
35,7 M US$ |
10,2% |
2026 |
| 449 | ZSTKZeroStack Corp. |
35,7 M US$ |
-335,6% |
2025 |
| 450 | VRCAVerrica Pharmaceuticals Inc. |
35,6 M US$ |
-50,3% |
2025 |